Please enable JavaScript to continue using this application.

Compare $IMMX vs $OBX | Chartloom

Compare

$IMMX vs $OBX

Immix Biopharma Inc · Obsidian Therapeutics, Inc

IMMX

Immix Biopharma Inc

OBX

Obsidian Therapeutics, Inc

Compare $IMMX vs $OBX

Comparing Immix Biopharma Inc and Obsidian Therapeutics, Inc

IMMXImmix Biopharma Inc

OBXObsidian Therapeutics, Inc

IMMXImmix Biopharma Inc

Market cap

$660M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

74.2%

52W performance

272.4%

FCF yield

-5.9%

OBXObsidian Therapeutics, Inc

Market cap

$803M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-61.8%

52W performance

-61.8%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMMX

OBX

Detailed metrics comparison

IMMX

Immix Biopharma Inc

OBX

Obsidian Therapeutics, Inc

Market Cap

IMMX$660M

OBX$803M

Enterprise Value

IMMX$435M

OBX$803M

Price

IMMX$9.46

OBX$13.00

P/E Ratio

IMMXN/A

OBXN/A

P/S Ratio

IMMX0.00x

OBX0.00x

EV/Sales

IMMX0.00x

OBX0.00x

EV/EBITDA

IMMX0.00x

OBX0.00x

P/B Ratio

IMMX3.03x

OBXN/A

P/FCF Ratio

IMMXN/A

OBXN/A

EV/FCF

IMMX-11.12x

OBX0.00x

PEG Ratio

IMMXN/A

OBXN/A

Forward P/E (NTM)

IMMXN/A

OBXN/A

Forward P/S (NTM)

IMMXN/A

OBXN/A

Revenue (TTM)

IMMX$0

OBX$0

Revenue Growth (YoY)

IMMXN/A

OBXN/A

Forward Rev Growth

IMMX452.1%

OBX0.0%

Gross Margin (TTM)

IMMX0.0%

OBX0.0%

Operating Margin (TTM)

IMMX0.0%

OBX0.0%

EBITDA Margin (TTM)

IMMX0.0%

OBX0.0%

Net Margin (TTM)

IMMX0.0%

OBX0.0%

FCF Margin (TTM)

IMMXN/A

OBXN/A

Net Income (TTM)

IMMX$-40M

OBXN/A

FCF (TTM)

IMMX$-39M

OBX$0

EPS (TTM)

IMMX-$0.63

OBX$0.00

ROE (TTM)

IMMX-3844.0%

OBX0.0%

ROA (TTM)

IMMX-3472.0%

OBX0.0%

ROIC (TTM)

IMMX-3844.0%

OBX0.0%

Cash

IMMX$225M

OBX$0

Debt

IMMX$0

OBX$0

Net Cash/Debt

IMMX$225M

OBX$0

Current Ratio (TTM)

IMMX25.13x

OBX0.00x

Quick Ratio (TTM)

IMMX24.98x

OBX0.00x

Debt/Equity (TTM)

IMMX0.00x

OBX0.00x

Debt/Assets (TTM)

IMMX0.0%

OBX0.0%

Interest Coverage (TTM)

IMMXN/A

OBXN/A

Net Debt/EBITDA (TTM)

IMMX0.00x

OBX0.00x

Beta

IMMX0.22

OBX5.86

52W Performance

IMMX272.4%

OBX-61.8%

YTD Performance

IMMX74.2%

OBX-61.8%

% from 52W High

IMMX-37.4%

OBX-74.0%

% from 52W Low

IMMX309.5%

OBX7.7%

Asset Turnover (TTM)

IMMX0.00x

OBX0.00x

FCF Yield (TTM)

IMMX-5.9%

OBX0.0%

Earnings Yield (TTM)

IMMX-6.0%

OBX0.0%

Dividend Yield (TTM)

IMMXN/A

OBXN/A

Rule of 40

IMMX0.0

OBX0.0

EV/GP/RG

IMMXN/A

OBXN/A

Ticker research

View IMMX research View OBX research

Metric	IMMX Immix Biopharma Inc	OBX Obsidian Therapeutics, Inc
Market & Valuation
Market Cap	$660M	$803M
Enterprise Value	$435M	$803M
Price	$9.46	$13.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.03x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-11.12x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	452.1%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-40M	N/A
FCF (TTM)	$-39M	$0
EPS (TTM)	-$0.63	$0.00
ROE (TTM)	-3844.0%	0.0%
ROA (TTM)	-3472.0%	0.0%
ROIC (TTM)	-3844.0%	0.0%
Financial Health
Cash	$225M	$0
Debt	$0	$0
Net Cash/Debt	$225M	$0
Current Ratio (TTM)	25.13x	0.00x
Quick Ratio (TTM)	24.98x	0.00x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.22	5.86
52W Performance	272.4%	-61.8%
YTD Performance	74.2%	-61.8%
% from 52W High	-37.4%	-74.0%
% from 52W Low	309.5%	7.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-5.9%	0.0%
Earnings Yield (TTM)	-6.0%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMMX research	View OBX research

Valuation

P/S Ratio

IMMX

0.00x

OBX

0.00x

EV/FCF

IMMX

-11.12x

OBX

0.00x

Growth & revenue

Forward Revenue Growth

IMMX

452.1%

OBX

0.0%

Profitability & performance

Gross Margin

IMMX

0.0%

OBX

0.0%

ROE

OBX

0.0%

IMMX

-3844.0%

FCF Yield %

OBX

0.0%

IMMX

-5.9%

52-Week Performance

IMMX

272.4%

OBX

-61.8%

Detailed metrics comparison

IMMX

Immix Biopharma Inc

OBX

Obsidian Therapeutics, Inc

Market Cap

IMMX$660M

OBX$803M

Enterprise Value

IMMX$435M

OBX$803M

Price

IMMX$9.46

OBX$13.00

P/E Ratio

IMMXN/A

OBXN/A

P/S Ratio

IMMX0.00x

OBX0.00x

EV/Sales

IMMX0.00x

OBX0.00x

EV/EBITDA

IMMX0.00x

OBX0.00x

P/B Ratio

IMMX3.03x

OBXN/A

P/FCF Ratio

IMMXN/A

OBXN/A

EV/FCF

IMMX-11.12x

OBX0.00x

PEG Ratio

IMMXN/A

OBXN/A

Forward P/E (NTM)

IMMXN/A

OBXN/A

Forward P/S (NTM)

IMMXN/A

OBXN/A

Revenue (TTM)

IMMX$0

OBX$0

Revenue Growth (YoY)

IMMXN/A

OBXN/A

Forward Rev Growth

IMMX452.1%

OBX0.0%

Gross Margin (TTM)

IMMX0.0%

OBX0.0%

Operating Margin (TTM)

IMMX0.0%

OBX0.0%

EBITDA Margin (TTM)

IMMX0.0%

OBX0.0%

Net Margin (TTM)

IMMX0.0%

OBX0.0%

FCF Margin (TTM)

IMMXN/A

OBXN/A

Net Income (TTM)

IMMX$-40M

OBXN/A

FCF (TTM)

IMMX$-39M

OBX$0

EPS (TTM)

IMMX-$0.63

OBX$0.00

ROE (TTM)

IMMX-3844.0%

OBX0.0%

ROA (TTM)

IMMX-3472.0%

OBX0.0%

ROIC (TTM)

IMMX-3844.0%

OBX0.0%

Cash

IMMX$225M

OBX$0

Debt

IMMX$0

OBX$0

Net Cash/Debt

IMMX$225M

OBX$0

Current Ratio (TTM)

IMMX25.13x

OBX0.00x

Quick Ratio (TTM)

IMMX24.98x

OBX0.00x

Debt/Equity (TTM)

IMMX0.00x

OBX0.00x

Debt/Assets (TTM)

IMMX0.0%

OBX0.0%

Interest Coverage (TTM)

IMMXN/A

OBXN/A

Net Debt/EBITDA (TTM)

IMMX0.00x

OBX0.00x

Beta

IMMX0.22

OBX5.86

52W Performance

IMMX272.4%

OBX-61.8%

YTD Performance

IMMX74.2%

OBX-61.8%

% from 52W High

IMMX-37.4%

OBX-74.0%

% from 52W Low

IMMX309.5%

OBX7.7%

Asset Turnover (TTM)

IMMX0.00x

OBX0.00x

FCF Yield (TTM)

IMMX-5.9%

OBX0.0%

Earnings Yield (TTM)

IMMX-6.0%

OBX0.0%

Dividend Yield (TTM)

IMMXN/A

OBXN/A

Rule of 40

IMMX0.0

OBX0.0

EV/GP/RG

IMMXN/A

OBXN/A

Ticker research

View IMMX research View OBX research

Metric	IMMX Immix Biopharma Inc	OBX Obsidian Therapeutics, Inc
Market & Valuation
Market Cap	$660M	$803M
Enterprise Value	$435M	$803M
Price	$9.46	$13.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.03x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-11.12x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	452.1%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-40M	N/A
FCF (TTM)	$-39M	$0
EPS (TTM)	-$0.63	$0.00
ROE (TTM)	-3844.0%	0.0%
ROA (TTM)	-3472.0%	0.0%
ROIC (TTM)	-3844.0%	0.0%
Financial Health
Cash	$225M	$0
Debt	$0	$0
Net Cash/Debt	$225M	$0
Current Ratio (TTM)	25.13x	0.00x
Quick Ratio (TTM)	24.98x	0.00x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.22	5.86
52W Performance	272.4%	-61.8%
YTD Performance	74.2%	-61.8%
% from 52W High	-37.4%	-74.0%
% from 52W Low	309.5%	7.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-5.9%	0.0%
Earnings Yield (TTM)	-6.0%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMMX research	View OBX research